Abstract | OBJECTIVE: METHODS: Isolated hearts from Wistar rats were perfused on a Langendorff system with Krebs-Henseleit buffer and pretreated with sphingosine-1-phosphate (10 nmol/L) before ischemia-reperfusion. Infarct size was measured by triphenyl tetrazolium chloride staining (n ≥ 6 per group). Cardiac edema was assessed by calculating total water content (n = 7 per group) and histologically quantifying the interstitial compartment (n ≥ 3 per group). The post-ischemic coronary release of syndecan-1 was quantified using ELISA. Syndecan-1 immunostaining intensity was assessed in perfusion-fixed hearts (n ≥ 3 per group). RESULTS: CONCLUSION: These results suggest that sphingosine-1-phosphate-induced cardioprotection against ischemia-reperfusion injury is not mediated by the maintenance of syndecan-1 in the endothelial glycocalyx.
|
Authors | Hala Araibi, Elizabeth van der Merwe, Asfree Gwanyanya, Roisin Kelly-Laubscher |
Journal | Microcirculation (New York, N.Y. : 1994)
(Microcirculation)
Vol. 27
Issue 5
Pg. e12612
(07 2020)
ISSN: 1549-8719 [Electronic] United States |
PMID | 32017300
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 John Wiley & Sons Ltd. |
Chemical References |
- Lysophospholipids
- Syndecan-1
- sphingosine 1-phosphate
- Sphingosine
|
Topics |
- Animals
- Endothelium, Vascular
(metabolism, pathology)
- Glycocalyx
(metabolism, pathology)
- Lysophospholipids
(metabolism, pharmacology)
- Male
- Myocardial Reperfusion Injury
(metabolism, pathology)
- Myocardium
(metabolism, pathology)
- Rats
- Rats, Wistar
- Sphingosine
(analogs & derivatives, metabolism, pharmacology)
- Syndecan-1
(metabolism)
|